Effectiveness and safety of neuraminidase inhibitors in reducing influenza complications: a meta-analysis of randomized controlled trials | Zendy

M. E. Falagas | Zendy; Patra Koletsi | Zendy; Evridiki K. Vouloumanou | Zendy; Petros I. Rafailidis | Zendy; Anastasios Kapaskelis | Zendy; Jordi Rello | Zendy

Open Access

Effectiveness and safety of neuraminidase inhibitors in reducing influenza complications: a meta-analysis of randomized controlled trials

Author(s) -

M. E. Falagas,

Patra Koletsi,

Evridiki K. Vouloumanou,

Petros I. Rafailidis,

Anastasios Kapaskelis,

Jordi Rello

Publication year - 2010

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkq158

Subject(s) - medicine , relative risk , randomized controlled trial , placebo , meta analysis , confidence interval , zanamivir , subgroup analysis , neuraminidase inhibitor , oseltamivir , surgery , pathology , covid-19 , disease , infectious disease (medical specialty) , alternative medicine

Several studies suggest that neuraminidase inhibitors (NIs) can reduce the duration of influenza symptoms. However, data regarding their effectiveness in reducing influenza complications are scarce.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research